Morningstar

Labcorp Holdings Inc LH

Morningstar Rating
Unlock
Stock XNYS Rating as of
$219.00 −0.20 (0.09%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
LH is trading at a 374% premium.
Price
$219.00
Fair Value
$854.00
Uncertainty
Medium
1-Star Price
$672.21
5-Star Price
$436.30
Economic Moat
Kcwdrl
Capital Allocation
Ktkqtmpfjd

Bulls Say, Bears Say

Bulls

Now that commercial payers are moving away from exclusive contracts with the large independent labs, we think the prospect of cutthroat pricing competition has eased.

Bears

If significant numbers of hospital-based labs are ill-equipped to comply with Medicare's payment reporting requirements, then reimbursement pressure could increase even more in 2025-27.

Show More

News

View All

Trading Information

Previous Close Price
$219.20
Day Range
$217.50–219.94
52-Week Range
$191.97–238.47
Bid/Ask
$216.51 / $231.75
Market Cap
$18.39 Bil
Volume/Avg
284,373 / 543,161

Key Statistics

Price/Earnings (Normalized)
15.31
Price/Sales
1.50
Dividend Yield (Trailing)
1.32%
Dividend Yield (Forward)
1.32%
Total Yield
7.30%

Company Profile

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Value
Total Number of Employees
67,000
Website
https://www.labcorp.com

Competitors

Valuation

View More
Metric
LH
SHL
MYGN
Price/Earnings (Normalized)
 15.3125.07536.94
Price/Book Value
 2.291.653.31
Price/Sales
 1.501.452.93
Price/Cash Flow
 11.4312.11—
Price/Earnings
LH
SHL
MYGN

Financial Strength

Metric
LH
SHL
MYGN
Quick Ratio
 0.620.861.44
Current Ratio
 0.881.011.96
Interest Coverage
 4.394.49−48.66
Quick Ratio
LH
SHL
MYGN

Profitability

Metric
LH
SHL
MYGN
Return on Assets (Normalized)
 5.39%3.75%0.46%
Return on Equity (Normalized)
 11.25%6.67%0.70%
Return on Invested Capital (Normalized)
 7.35%4.07%0.67%
Return on Assets
LH
SHL
MYGN

Diagnostics & Research Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
WqnbtwrpznNdpvx$234.1 Bil
 Danaher Corp
DHR
MmqzhjfzxDsjkpth$197.8 Bil
 IQVIA Holdings Inc
IQV
JdvlvsrzbPtwyhp$42.2 Bil
 Agilent Technologies Inc
A
GsjwcmktfNsvy$42.1 Bil
 IDEXX Laboratories Inc
IDXX
TxsrkhmvvXjqz$40.0 Bil
 Mettler-Toledo International Inc
MTD
XkrgmjhxvLvxjj$31.8 Bil
 Icon PLC
ICLR
CsnwyzbmDdznth$24.4 Bil
 Illumina Inc
ILMN
PmbbpcyLfrgwts$22.1 Bil
 Waters Corp
WAT
ZqgkycgqwKjxj$21.1 Bil

Sponsor Center